The largest database of trusted experimental protocols

5 protocols using lncap

1

Cell Line Cultivation and Derivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T, LnCap, and PC3 were obtained from ATCC and were propagated according to ATCC datasheets. LnCap-CR were generated by culturing LnCap cells in RPMI medium supplemented with 10% charcoal-stripped FBS (#S181F; Biowest) for more than 2 months. PrEC cells were purchased from Lonza (CC-2555) and propagated according to the manufacturer’s data sheet.
+ Open protocol
+ Expand
2

Culturing Prostate Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PCa cell lines PC-3 (CLR-1435) and LNCaP (CRL-1740) were obtained from American Type Culture Collection (ATCC) and cultured as follows: LNCaP in RPMI 1640 (L0495, Biowest, Logan, UT, USA), PC-3 in F-12K (21127-022, Life Technologies, Carlsbad, CA, USA) plus 10% fetal bovine serum (FBS; S181P, Biowest) in a humidified incubator with a 5% CO2 atmosphere at 37ºC.
+ Open protocol
+ Expand
3

Cell Culture Conditions for Human Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colon cell lines, HT29 (ATCC Cat# HTB-38) and HCT116 (ATCC Cat# CCL-247), were grown in DMEM High-Glucose Medium (Biowest, Nuaillé, France), while the human prostate cell lines, PC3 (ATCC Cat# CRL-1435) and LNCaP (ATCC Cat# CRL-1740), were grown in Ham’s F12 (Biowest, Nuaillé, France) and RPMI 1640 (Biowest, Nuaillé, France), respectively. All media were supplemented with 2 mM glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 10% fetal bovine serum (FBS, Gibco, Fisher Scientific Italia, Segrate (MI), Italia)). The cells were grown at 37 °C in a humified 5% CO2 atmosphere.
+ Open protocol
+ Expand
4

Prostate Cancer Cell Lines Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T, human prostate adenocarcinoma LNCaP, Du145 and PC3 cells lines were purchased from the American Type Culture Collection, Manassas, VA, USA. The Docetaxel resistant cell lines Du145 and PC3 were developed as previously described [31 (link)]. HEK293T were cultured in DMEM (BioWest, Nuaillé, France), Docetaxel sentitive and resistant Du145 cells and LNCaP cells were cultured in RPMI-1640 (BioWest) and PC3 DS and PC3 DR in F12K nutrient mixture medium (Thermo Fisher Scientific, Waltham, MA, USA). Culture media were supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine, 100 U of penicillin/ml, 100 μg of streptomycin/ml, and 0.1 mM non-essential amino acids (all from BioWest). Docetaxel resistant cell lines were maintained with 2.5 nM of Docetaxel (Sigma-Aldrich, St. Louis, MO). Antibody to PTOV1 was produced and purified as previously described [8 (link), 9 (link)]. Additional antibodies were obtained from: goat anti-actin (I-19) (Santa Cruz Biotechnology, Santa Cruz, CA); mouse anti-HA.11 (16B12) (Covance, MA); mouse anti-Cyclin B1(V152) (Abcam, Cambridge, MA); rabbit anti-PARP1 (H-250) (Santa Cruz Biotechnology). Lentiviral vectors carrying short-hairpin RNA (shRNA, TRCN0000143905, TRCN0000140104 and TRCN0000139737) to PTOV1 were obtained from Sigma.
+ Open protocol
+ Expand
5

Prostate Cancer Cell Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The prostate cancer cell lines PC-3 (CLR-1435) and Lncap (CRL-1740) were obtained from American Type Culture Collection (ATCC) and cultured as follows: Lncap in RPMI 1640 (L0495; Bio-West, Logan, UT, USA), PC-3 in F-12K (21127-022; Life Technologies, Carlsbad, CA, USA) plus 10% fetal bovine serum (FBS; S181P; Bio-West) in a humidified incubator with a 5% CO 2 atmosphere at 37°C. Then, the indicated concentrations of dihydrotestosterone (DHT), FGF-8b, and the inhibitors were added, respectively, to the culture medium which has been replaced with serum-free fresh medium.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!